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ABSTRACT
Gestational trophoblastic disease (GTD) 
is a condition of uncertain etiology, com-
prised of a hydatidiform mole (complete 
and partial), invasive mole, choriocarcino-
ma, epithelioid trophoblastic tumour and 
placental site trophoblastic tumour.
A partial hydatidiform mole develops 
when dispermy occurs, and the resulting 
conceptus is triploidy. 
A 26-year-old woman (Gravida 2, Para 
1, with one previous vaginal delivery of a 
normal female infant) was 16 weeks preg-
nant and was scheduled for emergency 
surgical treatment. She was diagnosed with 
a hydatidiform mole and eclampsia in our 
hospital for further treatment.
Her pre-treatment beta human chorionic 
gonadotropin (β-HCG) level was extreme-
ly high at 1,082,900 mIU/ml. The obste-
tricians considered septic complications 
from the hydatidiform mole and we decid-
ed to perform an emergency Sectio parva.
Two weeks after delivery, the serum β-hCG 
level was 16,341 mlU/mL and normalized 
gradually within two months without any 
cytotoxic therapy.
Partial mole hydatidosa (PMH), as a milder 
form of GTD, can go along with malignant 
complications with fatal consequences.
Key words: gestational trophoblastic disease, 
eclampsia, chorionic gonadotropin beta sub-
unit.
INTRODUCTION
Gestational trophoblastic disease (GTD) 
is a condition of uncertain etiology, com-
prised of a hydatidiform mole (complete 
and partial), invasive mole, choriocarcino-
ma, epithelioid trophoblastic tumour and 
placental site trophoblastic tumour. (1) 
The incidence of a complete hydatidiform 
mole is approximately 1 in 1,500 pregnan-
cies in the United States. The incidence of a 
partial hydatidiform mole is approximately 
1 in 750 pregnancies.
A complete hydatidiform mole is usually 
due to an androgenetic diploid conception, 
in which a haploid sperm fertilizes an egg 
that lacks female chromosomes. (2) 
A partial hydatidiform mole (PHM) devel-
ops when dispermy occurs, and the result-
ing conceptus is triploidy. (1) 
CASE REPORT
In this case report we describe a patient 
with symptoms of eclampsia induced by 
molar pregnancy. 
A 26-year-old woman (Gravida 2, Para 1, 
with one previous vaginal delivery of a nor-
mal female infant) was 16 weeks pregnant 
and was scheduled for emergency surgical 
treatment. She was diagnosed with a hyda-
tidiform mole and eclampsia, and kept in 
our hospital for further treatment. She had 
no medical or surgical history, and her vital 
signs upon admission were 70/100 mm Hg, 
88/min-18/min-36.90C.
On admission she had irregular vaginal 
bleeding, lower abdominal pain, syncopa, 
headache, excessive vomiting, transvagi-
nal expulsion of grape-like vesicles, an ab-
normally enlarged uterus and features of 
eclampsia. Her pre-treatment beta human 
chorionic gonadotropin (β-HCG) level was 
extremely high at 1,082,900 mIU/ml (nor-
mal: 0.5-2.9 mIU/ml).
Her base line investigation showed Hb-
132g/L, PLT-278x109/L, normal differen-
tial count, ABO/Rh B +ve, proteinuria 3+ 
dipstick and Thyrotropin (TSH) was 1.88 
uIU/ml with normal free thyroxine (FT 4). 
Her blood sugar level, renal and liver func-
tion tests were all within normal limits. 
An ultrasound examination performed 
on admission showed a viable fetus with 
Figure 1. CT scan (120 kV, 436 mA, IV 
contrast) A: pneumomediastinum (PM), 
left side pneumothorax (PT) and subcu-
taneous emphysema (SE); B: pneumoperi-
cardium of 4 mm.
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normal anatomy and placenta located at 
the posterior uterine wall, and a second 
multicystic molar-appearing placenta. The 
ovaries showed bilateral multilocular cystic 
masses with a dimension of 70x40 mm.
The magnetic resonance imaging (MRI) 
of the brain showed hypodense lesions at 
the gray-white matter junction and diffuse 
cerebral edema primarily in the parieto-
occipital lobe, frontal and inferior temporal 
lobes. 
The obstetricians suspected eclampsia and 
magnesium sulphate and sodium thiopen-
tal were administered repeatedly, but they 
were not effective for controlling the blood 
pressure and heart rate. The obstetricians 
considered septic complications from the 
hydatidiform mole and it was decided that 
an emergency sectio parva under general 
anaesthesia would be performed. 
On pathological examination, the placenta 
was 22×16×4 cm, weight 422.5 g. The mi-
croscopic findings consisted of partial mole 
hydatidosa with trophoblastic atypias, mild 
hyperplasia and spontaneous degeneration 
areas. The pathology diagnosis was gesta-
tional trophoblastic disease – partial mole 
hydatidosa (PMH).
At the end of the 40 minute operation, the 
patient was sent to the recovery room in an 
intubated state. Her estimated blood loss 
was 200 ml and 500 ml crystalloid was in-
fused (figure 1).
In the Intensive Care Unit, and on the first 
day after the operation, the patient was put 
on mechanical ventilation and developed 
right side paralysis, amaurosis, hypopro-
teinemia (40 g/L).
Postoperatively, she received parenteral 
therapy: antibiotics meropenem and met-
ronidazol antimycotics aciklovir, human 
albumins, antiepileptics drug levetiracet-
am, crystalloid and colloids solutions.
Seven days after the operation, subsequent 
investigations confirmed normal thyroid 
function tests, normal vision, normal 
blood pressure, no proteinuria and a nor-
mal chest X-ray.
Two weeks after delivery, the serum β-hCG 
level was 16,341 mlU/mL and normalized 
gradually within two months without any 
cytotoxic therapy and with no evidence of 
persistent or metastatic disease. Careful 
follow-up has so far shown no sign of per-
sistent trophoblastic disease (table 1).
The patient has been transferred to the In-
stitute of Physical Medicine and Rehabili-
tation “Dr. Miroslav Zotović” for physical 
therapy.
DISCUSSION
In our case the patient was presented with 
partial molar pregnancy with symptoms of 
eclampsia prior to 20 weeks’ gestation. 
Ultrasonography made possible a diagno-
sis of a hydatidiform mole and co-existent 
fetus in the first trimester. (3) 
Partial moles derive from dispermic fertili-
zation of a haploid normal oocyte and pro-
duce a triploid set of chromosomes. Com-
plete and partial moles have distinct fetal 
and maternal complications. In the com-
bination of a partial hydatidiform mole, 
the fetus is almost always triploid and the 
indication for a termination of pregnancy 
is evident. (4) 
Eclampsia is associated with blood pres-
sure ≥ 160/110 mm Hg, proteinuria ≥ 2+ 
dipstick, persistent headache or other cer-
ebral or visual disturbance, elevated serum 
transaminase levels, platelets <100 000/µL, 
persistent epigastric pain and seizures that 
cannot be attributed to other causes. (5) 
CONCLUSION
The occurrence of eclampsia before 20 
weeks’ gestation is rather rare and is often 
combined with the occurrence of GTD. It 
is important to recognize the symptoms of 
both conditions promptly and to then treat 
them adequately. 
Table 1. Evolution of beta-HCG levels.
Evolution of beta-HCG levels.
Date beta-HCG (UI/ml)







Beta-HCG: beta human chorionic gonadotropin
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